The global hemophilia market is anticipated to grow with a significant CAGR of 6% during the forecast period. The hemophilia market growth is owing to the increasing demand for the prophylactic treatment of hemophilia. In addition to this, the increasing engagement of healthcare professionals, hemophilia treatment centers, as well as hemophilia societies to improve the care of hemophilia patients and their quality of life is also expected to drive the hemophilia market shares. Moreover, the continuous evolving treatment of hemophilia in recent years is also anticipated to propel the growth of the hemophilia market.
In general, the treatment of monogenetic bleeding disorders that is hemophilia A and B was done with the systemic protein replacement therapy. However, in recent years, a variety of diverse molecular medicines, ranging from antibody to gene to RNA therapy are transforming the treatment of hemophilia.
Moreover, the traditional replacement therapy used in the treatment of hemophilia required intravenous infusions of the factors for two to three times a week. While the new therapies in the market with extended half-life products are expected to reduce the frequency of injections. Additionally, multiple gene-editing techniques are under clinical or preclinical investigation for the treatment of hemophilia. Therefore, these new therapies and approaches that are being tested or launched are anticipated to considerably drive the size of the hemophilia industry during the forecast period.
OMR Global Recently Published Report on: https://www.omrglobal.com/industry-reports/hemophilia-market
Global Hemophilia Market- Segmentation
By Type
- Hemophilia A
- Hemophilia B
- Others
By Therapy
- Replacement Therapy
- Gene Therapy
- Others
By Product Type
- Recombinant Coagulation Factor Concentrates
- Plasma-derived Coagulation Factor Concentrates
- Others
To Learn More About this Report Request a Free Sample Copy @ https://www.omrglobal.com/request-sample/hemophilia-market
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
